No Detail Found!

Effect of Nebulized Magnesium Sulphate in Terms of the In-Hospital Outcome of Patients Admitted with Acute Exacerbation of Chronic Obstructive Pulmonary disease

Author(s)
Qurratul Ain Central Park Medical College, Lahore, Pakistan
Fawad Ahmad Randhawa King Edward Medical University, Lahore, Pakistan
Nasir Farooq Butt King Edward Medical University, Lahore, Pakistan
Ayesha Aslam King Edward Medical University, Lahore, Pakistan
Hina Latif King Edward Medical University, Lahore, Pakistan
Rabia Rathore King Edward Medical University, Lahore, Pakistan
Abstract
Objective: To evaluate the efficacy of Magnesium Sulphate (MgSO4) with the conventional treatment in acute exacerbation chronic obstructive pulmonary disease (AECOPD) Methods: This Quasi-experimental study was conducted in Department of Internal Medicine from July 2020 to July 2022. The study involved 160 patients in total. There were two groups of patients. Group A was nebulized with 250mg of MgSO4 four times a day along with conventional treatment. Group B was given only conventional treatment. Conventional treatment included oxygen inhalation, anti-cholinergic and beta-2 agonist nebulization, intravenous steroids, and intravenous antibiotics. Both groups were followed for five days to assess the effect of nebulized magnesium. Results: Group A required assisted ventilation for 2-3 days for 28% of the subjects (22 patients out of 80), while group B required it for 81% of the subjects (65 patients out of 80). In addition, only 9% of patients in group A and 8% of patients in group B needed assisted ventilation for four to five days. In comparison to group A, which had 33% of patients discharged on the fourth day and 20% on the fifth day or later, group B saw 53% of patients discharged on the fourth day and 20% on the fifth day or later. The results showed that PCO2 and peak expiratory flow rate (PEFR) have a significant variance between group A and group B and values have no significant variance between group A and group B on the first day and the last day. Conclusion: Nebulized supplementation improves in-hospital outcomes in patients presenting with acute exacerbation of COPD as compared to the patients not receiving nebulized magnesium sulphate.
Publication Details
Page(s) 383-387
DOI DOI not available
Published Journal: Journal of Pakistan Society of Internal Medicine, Volume: 5, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
Acute exacerbation, chronic obstructive pulmonary disease (COPD), Nebulized Magnesium Sulphate
0

Citations

0

Downloads

42

Views